2019
DOI: 10.1002/adma.201901633
|View full text |Cite
|
Sign up to set email alerts
|

Materials for Immunotherapy

Abstract: Breakthroughs in materials engineering have accelerated the progress of immunotherapy in preclinical studies. The interplay of chemistry and materials has resulted in improved loading, targeting, and release of immunomodulatory agents. An overview of the materials that are used to enable or improve the success of immunotherapies in preclinical studies is presented, from immunosuppressive to proinflammatory strategies, with particular emphasis on technologies poised for clinical translation. The materials are o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
114
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 149 publications
(120 citation statements)
references
References 671 publications
(761 reference statements)
1
114
0
Order By: Relevance
“…To remedy this, PLGA was blended into the particles. This biodegradable and FDA‐approved polymer has demonstrated superior uptake by macrophage phagocytosis compared to other polymeric materials . The addition of PLGA led to a marked improvement of particle uptake compared to those without PLGA (Figure 3A).…”
Section: Resultsmentioning
confidence: 99%
“…To remedy this, PLGA was blended into the particles. This biodegradable and FDA‐approved polymer has demonstrated superior uptake by macrophage phagocytosis compared to other polymeric materials . The addition of PLGA led to a marked improvement of particle uptake compared to those without PLGA (Figure 3A).…”
Section: Resultsmentioning
confidence: 99%
“…The small molecular compounds generally lack tumor specificity, which could induce severe side effects because of nonspecific drug distribution in the normal tissues. [ 24–26 ] Therefore, it is highly desirable to spatiotemporally codeliver multiple immune modulators to the tumor site for combination immunotherapy. Among the various nanovectors exploited for codelivery of multiple therapeutic regimens, supramolecular nanocomplexes have shown considerable potential for targeted drug delivery and cancer therapy.…”
Section: Introductionmentioning
confidence: 99%
“…Nature is undoubtedly the most astonishing creator in regard to both beauty and functionality. Numerous bio-inspired designs [1][2][3][4][5][6][7][8][9], also called biomimetics or biomimicry, e.g., arts, structures, architectures, and materials, have been introduced as an innovative strategy translating complexity and diversity principles of function, performance, and aesthetics from biology to human technology and creativity for centuries. Mechanically active dressings to accelerate wound healing were inspired by embryonic wound closure [5].…”
Section: Introductionmentioning
confidence: 99%
“…An overview of the materials used to improve immunotherapies based on artificial cells and artificial microenvironments was presented. The materials were organized based on their characteristic length scale, whereby the enabling feature of each technology was organized by the structure of that material [7]. Endothelial cells representing the first biological barrier for compounds, including nanoparticles, administered via the intravascular route has been reported [8].…”
Section: Introductionmentioning
confidence: 99%